Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations
- 6 December 1995
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
- Vol. 1253 (2) , 136-140
- https://doi.org/10.1016/0167-4838(95)00167-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- HIV Protease as an Inhibitor Target for the Treatment of AIDSPublished by Elsevier ,1994
- Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencingNature, 1993
- PCR amplification of HIV-1 proteinase sequences directly from Lab isolates allows determination of five conserved domainsVirology, 1992
- Dynamic changes in HIV‐1 quasispecies from azidothymidine (AZT)‐treated patientsThe FASEB Journal, 1992
- Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assayAntimicrobial Agents and Chemotherapy, 1992
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular TropismsScience, 1987
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985